{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:16:18Z","timestamp":1761059778974},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/aci.0000000000000097","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T13:09:44Z","timestamp":1407416984000},"page":"485-489","source":"Crossref","is-referenced-by-count":10,"title":["Current options and emerging therapies for anterior ocular inflammatory disease"],"prefix":"10.1097","volume":"14","author":[{"given":"Basharut A.","family":"Syed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Bielory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anai.2012.01.006","article-title":"Allergic conjunctivitis and dry eye syndrome.","volume":"108","author":"Hom","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00130832-200410000-00014","article-title":"Ocular allergy and dry eye syndrome.","volume":"4","author":"Bielory","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R3-17-20210128","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajo.2008.06.003","article-title":"Bacteriologic profile of the conjunctiva in the patients with dry eye.","volume":"146","author":"Hori","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R4-17-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/ACI.0b013e328364d843","article-title":"Pharmacoeconomics of anterior ocular inflammatory disease.","volume":"13","author":"Bielory","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R5-17-20210128","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","article-title":"The epidemiology of ocular and nasal allergy in the United States.","volume":"126","author":"Singh","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R6-17-20210128","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/14656566.2013.802773","article-title":"Emerging therapies in allergic conjunctivitis and dry eye syndrome.","volume":"14","author":"Nye","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"R7-17-20210128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ajo.2011.02.026","article-title":"Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population.","volume":"152","author":"Galor","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis.","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"R9-17-20210128","first-page":"S102","article-title":"Prevalence, burden, and pharmacoeconomics of dry eye disease.","volume":"14","author":"Pflugfelder","year":"2008","journal-title":"Am J Manag Care"},{"key":"R10-17-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2415-9-13","article-title":"Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States.","volume":"9","author":"Smith","year":"2009","journal-title":"BMC Ophthalmol"},{"key":"R11-17-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2500\/aap.2012.33.3525","article-title":"Allergic conjunctivitis: the evolution of therapeutic options.","volume":"33","author":"Bielory","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"R12-17-20210128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14728210903103818","article-title":"Emerging drugs for conjunctivitis.","volume":"14","author":"Origlieri","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"R13-17-20210128","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/ACI.0b013e3282ef705b","article-title":"Chirality in ocular agents.","volume":"7","author":"Leonov","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R14-17-20210128","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12325-008-0096-9","article-title":"Efficacy of topical azithromycin ophthalmic solution 1 in the treatment of posterior blepharitis.","volume":"25","author":"Luchs","year":"2008","journal-title":"Adv Ther"},{"key":"R15-17-20210128","first-page":"2488","article-title":"Phase 3 study of efficacy and safety of once-daily olopatadine hydrochloride, 0.77 ophthalmic formulation in patients with allergic conjunctivitis using the ora conjunctival allergen challenge model (Ora-CACTM) (NCT01743027).","volume":"55","author":"McLaurin","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-17-20210128","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1358\/dot.2011.47.12.1709243","article-title":"Alcaftadine: a topical antihistamine for use in allergic conjunctivitis.","volume":"47","author":"Namdar","year":"2011","journal-title":"Drugs Today (Barc)"},{"key":"R17-17-20210128","first-page":"87","article-title":"Evaluation of alcaftadine 0.25 ophthalmic solution in acute allergic conjunctivitis at 15 min and 16h after instillation versus placebo and olopatadine 0.1.","volume":"5","author":"Greiner","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R18-17-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1331\/JAPhA.2010.10505","article-title":"New drugs: asenapine, iloperidone, and bepotastine besilate.","volume":"50","author":"Hussar","year":"2010","journal-title":"J Am Pharm Assoc"},{"key":"R19-17-20210128","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","article-title":"Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis.","volume":"41","author":"Calderon","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"R20-17-20210128","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2165\/11207450-000000000-00000","article-title":"Ketorolac 0.45 ophthalmic solution.","volume":"28","author":"McCormack","year":"2011","journal-title":"Drugs Aging"},{"key":"R21-17-20210128","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/jm801512v","article-title":"Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration.","volume":"52","author":"Robinson","year":"2009","journal-title":"J Med Chem"},{"key":"R22-17-20210128","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/ACI.0b013e32834a4e01","article-title":"Allergic complications with laser-assisted in-situ keratomileusis.","volume":"11","author":"Bielory","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R24-17-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1517\/13543784.13.1.47","article-title":"Diquafosol tetrasodium: a novel dry eye therapy.","volume":"13","author":"Nichols","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"R25-17-20210128","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.ico.0000133993.14768.a9","article-title":"Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.","volume":"23","author":"Tauber","year":"2004","journal-title":"Cornea"},{"key":"R26-17-20210128","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/eye.2012.166","article-title":"Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.","volume":"26","author":"Kamiya","year":"2012","journal-title":"Eye (Lond)"},{"key":"R27-17-20210128","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.ophtha.2012.04.010","article-title":"Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.","volume":"119","author":"Matsumoto","year":"2012","journal-title":"Ophthalmology"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:41:29Z","timestamp":1636562489000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201410000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000097","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}